Daniel Green

Daniel Green is a seasoned professional in the healthcare and pharmaceutical sectors, currently serving as a Healthcare Analyst at Psagot Investment House since November 2022, where the focus is on analyzing small to mid-cap publicly traded pharmaceutical companies. Prior to this role, Daniel held positions in business development at Hiverr and as a Business Development Analyst at Telrad Networks, where responsibilities included managing acquisition processes and financial forecasting. Additional experience includes valuation analysis at Altshuler Shaham Benefits, market potential assessments at Verdune, and research work at Teva Pharmaceuticals. Daniel holds a Doctor of Medicine (MD) from Bar-Ilan University and a Bachelor of Arts in Biology from Yeshiva University, and is currently pursuing a Bachelor of Arts in Accounting at The Open University of Israel.